Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke.

Abstract

AIM:

Stroke results in long term serious disability that affect millions across the globe. Several clinical and preclinical studies have reinforced the therapeutic use of stem cells in stroke patients to enhance their quality of life. Previous studies from our lab have demonstrated that 1*105 allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) when given intraarterially (IA) render neuroprotection by modulating the expression of inflammasomes. Sirtuins are a class of important deacylases having a significant role in cellular functioning. Sirtuin-1 (SIRT-1) is an important enzyme essential for regulating cellular metabolism, which is reduced following an ischemic episode. The present study aims to unviel the role of MSCs in regulating the brain SIRT-1 levels following stroke and the involvement of SIRT-1 in regulating inflammasome signaling to reduce cellular apoptosis towards rendering neuroprotection.

MATERIALS AND METHODS:

6 h post-reversible middle cerebral artery occlusion (MCAo), ovariectomized Sprague Dawley (SD) rats were infused intraarterially with 1*105 MSCs. 24 h after MCAo animals were examined for functional and behavioral outcomes. Brains were collected for assessing size of infarct and neuronal morphology. Molecular and immunofluroscence studies were also performed for assessing changes in gene and protein expressions. Extent of apoptosis was also determined in different groups. Inhibition study with SIRT-1 specific inhibitor EX-527 was also performed.

RESULTS:

A reduction in infarct size and improvement in motor functional and behavioral outcomes following infusion of MSCs IA at 6 h post-stroke was observed. Increase in average neuronal density and neuronal length was also seen. Increased expression of SIRT-1, BDNF and concomitant reduction in the expression of different inflammatory and apoptotic markers in the brain cortical regions were observed following MSCs treatment.

CONCLUSION:

Our study provides a preliminary evidence that post-stroke IA MSCs therapy regulates SIRT-1 to modulate NF-κB pathway to mitigate inflammasome signaling and cellular apoptosis. This study using IA approach for administering MSCs is highly relevant clinically. Our study is the first to report that neuroprotective effects of IA MSCs in rodent focal ischemia is mediated by SIRT-1 regulation of inflammasome signaling.

• Authors: Deepaneeta Sarmah, Aishika Datta, Harpreet Kaur, Kiran Kalia, Anupom Borah, Anne Marie Rodriguez, Dileep R Yavagal, Pallab Bhattacharya
• Journal: Stem cell reviews and reports (Stem Cell Rev Rep) Vol. 18 Issue 2 Pg. 821-838 (02 2022) ISSN: 2629-3277 [Electronic] United States
• PMID: 35112234 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Chemical References

• Inflammasomes
• NF-kappa B
• Neuroprotective Agents
• Sirt1 protein, rat
• Sirtuin 1

Topics

• Animals
• Apoptosis
• Infarction, Middle Cerebral Artery (metabolism, therapy)
• Inflammasomes (metabolism)
• Ischemic Stroke (genetics, metabolism, therapy)
• Mesenchymal Stem Cell Transplantation (methods)
• Mesenchymal Stem Cells (cytology, metabolism)
• NF-kappa B (metabolism)
• Neuroprotective Agents (metabolism, pharmacology)
• Quality of Life
• Rats
• Rats, Sprague-Dawley
• Sirtuin 1 (genetics, metabolism)